ANGO vs STT · rev $292.5M vs P/E 17, $45.02B cap
AngioDynamics Inc (ANGO) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
State Street Corp (STT) is a asset management company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
STT does not have a complete income-statement cache yet.
ANGO currently screens at market cap $378.5M. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the ANGO and STT stock pages for the full models.
Not investment advice.